Aaron Goodman, Clinical Director BMT/cell therapy at MountainView Hospital, shared a post on X:
“Daratumumab prevents progression of asymptomatic to asymptomatic.
5≥60% Plasma cells in dara against 16 in control – no symptoms!
2 Anemias in dara against 14 in control (below arbitrary threshold 2 pts – lower limit).
10 Cases bone dz in dara against 18 control.
0 Fractures/0 renal failure”
Other articles featuring Dr. Goodman on OncoDaily.